Thromboembolic prophylaxis in total joint replacement

Chest

Volumn 120, Issue 1, 2001, Pages 302-304

  Pierson, Jeffery L ^a   Tavel, Morton E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; ESTROGEN; HEPARIN; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; DOSE RESPONSE; ESTROGEN THERAPY; FEMALE; HUMAN; JOINT PROSTHESIS; LUNG EMBOLISM; LUNG VENTILATION PERFUSION RATIO; MOBILIZATION; MORBIDITY; OSTEOARTHRITIS; PHLEBITIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME;

EID: 0034881093     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.120.1.302     Document Type: Article

References (5)

1. Symposium: Recent advances in venous thromboembolic prophylaxis during and after total hip replacement
2. Complications of heparin therapy after total joint arthroplasty
3. The use of heparin in patients in whom a pulmonary embolism is suspected after total hip arthroplasty
4. Warfarin prophylaxis to prevent mortality from pulmonary embolism after total hip replacement
5. The efficacy of prophylaxis with low-dose warfarin for prevention of pulmonary embolism following total hip arthroplasty